Updates to FDA's Processes and Their Impact on Medical Affairs Teams
Medical affairs teams must adapt to changing timelines and adjust their skillsets accordingly.
Pharmaceutical Companies' Reaction
According to Dr. William Soliman, pharmaceutical companies will likely react to the administration's efforts by compromising on prices for some branded drugs.
We’ve seen Pfizer doing a deal with Trump, and I think other companies will follow. If they can come to a compromise for even just some branded drugs, that’s a happy middle-ground.
Dr. Soliman believes that in exchange for dropping prices, pharmaceutical companies will push for the administration to push back tariffs, as seen in the Pfizer deal.
Timeline for Impact on Drug Pricing
Dr. Soliman notes that the impact on drug pricing will primarily be felt by elderly patients under Medicare, while the effect on those with commercial plans remains to be seen.
Autor's resume: Pharmaceutical companies adapt to FDA changes.
More News
- Liverpool 1 Man Utd 2: Match Review
- Breaking: CSU fires head football coach Jay Norvell after uneven start to 2025
- The constitution nobody wanted
- Fernandez beats Valentova in three sets to win singles crown at Japan Open
- In Review: Guillermo del Toro’s Frankenstein
- ASU Football shocks No. 7 Texas Tech after late game-winning drive - The Arizona State Press
- Canucks score 3 first-period goals, hang on to trip Capitals 4-3
- The study that estimates the numbers of Russian dead in Ukraine at 219,000